FI933037A0 - Tiazolylvinylfenylderivat - Google Patents
TiazolylvinylfenylderivatInfo
- Publication number
- FI933037A0 FI933037A0 FI933037A FI933037A FI933037A0 FI 933037 A0 FI933037 A0 FI 933037A0 FI 933037 A FI933037 A FI 933037A FI 933037 A FI933037 A FI 933037A FI 933037 A0 FI933037 A0 FI 933037A0
- Authority
- FI
- Finland
- Prior art keywords
- tiazolylvinylfenylderivat
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/907,987 US5273986A (en) | 1992-07-02 | 1992-07-02 | Cycloalkylthiazoles |
Publications (2)
Publication Number | Publication Date |
---|---|
FI933037A0 true FI933037A0 (fi) | 1993-07-01 |
FI933037A FI933037A (fi) | 1994-01-03 |
Family
ID=25424972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI933037A FI933037A (fi) | 1992-07-02 | 1993-07-01 | Tiazolylvinylfenylderivat |
Country Status (18)
Country | Link |
---|---|
US (2) | US5273986A (fi) |
EP (1) | EP0577003A1 (fi) |
JP (1) | JPH0680654A (fi) |
KR (1) | KR940005602A (fi) |
CN (1) | CN1087086A (fi) |
AU (1) | AU667107B2 (fi) |
BR (1) | BR9302737A (fi) |
CA (1) | CA2099295A1 (fi) |
CZ (1) | CZ133493A3 (fi) |
FI (1) | FI933037A (fi) |
HU (1) | HUT72747A (fi) |
IL (1) | IL106141A0 (fi) |
MX (1) | MX9303958A (fi) |
NO (1) | NO932399L (fi) |
NZ (1) | NZ247988A (fi) |
PL (1) | PL299544A1 (fi) |
UY (1) | UY23609A1 (fi) |
ZA (1) | ZA934603B (fi) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5830854A (en) * | 1992-12-14 | 1998-11-03 | Merck Sharp & Dohme, Limited | Method of treating cystic fibrosis using a tachykinin receptor antagonist |
AU3522895A (en) * | 1994-09-13 | 1996-03-29 | F. Hoffmann-La Roche Ag | A process of making (e)-4-{3-{2-(4-cycloalkyl-2-thiazolyl) ethenyl}phenyl}amino-2 ,2-alkyldiyl-4-oxobutanoic acid anoic acid |
RU2161612C2 (ru) * | 1994-10-14 | 2001-01-10 | Яманоути Фармасьютикал Ко., Лтд. | Производные азола, фармацевтическая композиция на их основе, промежуточные соединения |
AU5347496A (en) * | 1995-04-21 | 1996-11-07 | Daiichi Pharmaceutical Co., Ltd. | Ethynylthiazole derivative |
SE9804212D0 (sv) * | 1998-12-04 | 1998-12-04 | Astra Pharma Prod | Compounds |
US7056917B2 (en) * | 2001-04-26 | 2006-06-06 | Daiichi Pharmaceutical Co., Ltd. | Drug efflux pump inhibitor |
WO2002087589A1 (fr) * | 2001-04-26 | 2002-11-07 | Daiichi Pharmaceutical Co., Ltd. | Medicament permettant d'inhiber une pompe d'elimination de medicament |
SE0102299D0 (sv) * | 2001-06-26 | 2001-06-26 | Astrazeneca Ab | Compounds |
SE0102764D0 (sv) * | 2001-08-17 | 2001-08-17 | Astrazeneca Ab | Compounds |
GB0226930D0 (en) | 2002-11-19 | 2002-12-24 | Astrazeneca Ab | Chemical compounds |
EP2048137A1 (en) * | 2004-02-18 | 2009-04-15 | AstraZeneca AB | Benzamide derivatives and their use as glucokinase activating agents. |
BRPI0507734A (pt) * | 2004-02-18 | 2007-07-10 | Astrazeneca Ab | composto ou um sal, pró-droga ou solvato do mesmo, método de tratar doenças mediadas por glk, e, processo para a preparação de um composto |
TW200600086A (en) * | 2004-06-05 | 2006-01-01 | Astrazeneca Ab | Chemical compound |
GB0423044D0 (en) * | 2004-10-16 | 2004-11-17 | Astrazeneca Ab | Compounds |
AU2005293343B2 (en) | 2004-10-16 | 2009-03-19 | Astrazeneca Ab | Process for making phenoxy benzamide compounds |
GB0423043D0 (en) * | 2004-10-16 | 2004-11-17 | Astrazeneca Ab | Compounds |
US20110059941A1 (en) * | 2005-05-24 | 2011-03-10 | Peter William Rodney Caulkett | 2-phenyl substituted imidazol [4,5b] pyridine/pyrazine and purine derivatives as glucokinase modulators |
TW200714597A (en) * | 2005-05-27 | 2007-04-16 | Astrazeneca Ab | Chemical compounds |
EP1902052B1 (en) * | 2005-07-09 | 2012-11-28 | AstraZeneca AB | Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
EP2027113A1 (en) * | 2005-07-09 | 2009-02-25 | AstraZeneca AB | Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
WO2007007040A1 (en) * | 2005-07-09 | 2007-01-18 | Astrazeneca Ab | 2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes |
US9202182B2 (en) * | 2005-08-11 | 2015-12-01 | International Business Machines Corporation | Method and system for analyzing business architecture |
TW200738621A (en) * | 2005-11-28 | 2007-10-16 | Astrazeneca Ab | Chemical process |
TW200825063A (en) * | 2006-10-23 | 2008-06-16 | Astrazeneca Ab | Chemical compounds |
CL2007003061A1 (es) * | 2006-10-26 | 2008-08-01 | Astrazeneca Ab | Compuestos derivados de 3,5-dioxi-benzamida; proceso de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una enfermedad mediada a traves de glk, tal como la diabetes tipo 2. |
BRPI0721143A2 (pt) * | 2006-12-21 | 2014-03-11 | Astrazeneca Ab | Forma cristalina do composto processo para a formação da mesma, uso de um composto, método para tratar doenças mediadas por ativador de glicocinase |
AU2009278929B2 (en) | 2008-08-04 | 2012-07-05 | Astrazeneca Ab | Pyrazolo [3,4] pyrimidin-4-yl derivatives and their uses to treat diabetes and obesity |
GB0902434D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Chemical process |
GB0902406D0 (en) * | 2009-02-13 | 2009-04-01 | Astrazeneca Ab | Crystalline polymorphic form |
WO2010116176A1 (en) | 2009-04-09 | 2010-10-14 | Astrazeneca Ab | Pyrazolo [4, 5-e] pyrimidine derivative and its use to treat diabetes and obesity |
AR076220A1 (es) | 2009-04-09 | 2011-05-26 | Astrazeneca Ab | Derivados de pirazol [4,5 - e] pirimidina |
CN102647984B (zh) | 2009-10-02 | 2015-03-25 | 埃维克辛公司 | 抗炎症的2-羰基噻唑和2-羰基恶唑 |
CN105102438B (zh) | 2013-01-29 | 2019-04-30 | 埃维克辛公司 | 抗炎症和抗肿瘤的2-氧代噻唑类和2-氧代噻吩类化合物 |
GB201413695D0 (en) | 2014-08-01 | 2014-09-17 | Avexxin As | Compound |
GB201604318D0 (en) | 2016-03-14 | 2016-04-27 | Avexxin As | Combination therapy |
US20220324835A1 (en) * | 2018-01-26 | 2022-10-13 | Nurix Therapeutics, Inc. | Inhibitors of cbl-b and methods of use thereof |
CN114364667A (zh) | 2019-04-09 | 2022-04-15 | 紐力克斯治疗公司 | 用于Cbl-b抑制的3-取代哌啶类化合物以及Cbl-b抑制剂与癌症疫苗和/或溶瘤病毒联合的用途 |
JP2022532247A (ja) | 2019-05-17 | 2022-07-13 | ニューリックス セラピューティクス,インコーポレイテッド | Cbl-b阻害のためのシアノシクロブチル化合物及びその使用 |
US12016860B2 (en) | 2021-04-08 | 2024-06-25 | Nurix Therapeutics, Inc. | Combination therapies with Cbl-b inhibitor compounds |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62142168A (ja) * | 1985-10-16 | 1987-06-25 | Mitsubishi Chem Ind Ltd | チアゾ−ル誘導体及びそれを有効成分とするロイコトリエンきつ抗剤 |
JPS63258854A (ja) * | 1987-04-16 | 1988-10-26 | Mitsubishi Kasei Corp | カルボキシスチレン誘導体およびそれを有効成分とする薬剤 |
DE3723913A1 (de) * | 1987-07-18 | 1989-02-23 | Shell Agrar Gmbh & Co Kg | Neue phosphoniumsalze, ihre herstellung und verwendung |
EP0318085A3 (en) * | 1987-11-25 | 1990-03-14 | Merck Frosst Canada Inc. | Heterazole dialkanoic acids |
ES2052825T3 (es) * | 1988-07-15 | 1994-07-16 | Hoffmann La Roche | Derivados de cicloalquiltiazol. |
US5001140A (en) * | 1989-04-17 | 1991-03-19 | Hoffmann-La Roche Inc. | Cycloalkylthiazoles |
JPH02169583A (ja) * | 1988-12-22 | 1990-06-29 | Mitsubishi Kasei Corp | ビニルチアゾール誘導体およびそれを有効成分とする薬剤 |
AU654140B2 (en) * | 1990-07-31 | 1994-10-27 | Lilly Industries Limited | N-benzyl indoles, processes for their preparation or pharmaceutical compositions containing them |
-
1992
- 1992-07-02 US US07/907,987 patent/US5273986A/en not_active Expired - Fee Related
-
1993
- 1993-06-24 EP EP93110073A patent/EP0577003A1/en not_active Withdrawn
- 1993-06-25 ZA ZA934603A patent/ZA934603B/xx unknown
- 1993-06-25 NZ NZ247988A patent/NZ247988A/en unknown
- 1993-06-25 IL IL106141A patent/IL106141A0/xx unknown
- 1993-06-28 CA CA002099295A patent/CA2099295A1/en not_active Abandoned
- 1993-06-28 HU HU9301881A patent/HUT72747A/hu unknown
- 1993-06-28 AU AU41562/93A patent/AU667107B2/en not_active Expired - Fee Related
- 1993-06-29 JP JP5185437A patent/JPH0680654A/ja active Pending
- 1993-06-30 UY UY23609A patent/UY23609A1/es unknown
- 1993-06-30 MX MX9303958A patent/MX9303958A/es unknown
- 1993-07-01 BR BR9302737A patent/BR9302737A/pt not_active Application Discontinuation
- 1993-07-01 CN CN93109528A patent/CN1087086A/zh active Pending
- 1993-07-01 CZ CZ931334A patent/CZ133493A3/cs unknown
- 1993-07-01 KR KR1019930012260A patent/KR940005602A/ko not_active Application Discontinuation
- 1993-07-01 NO NO932399A patent/NO932399L/no unknown
- 1993-07-01 FI FI933037A patent/FI933037A/fi not_active Application Discontinuation
- 1993-07-01 PL PL29954493A patent/PL299544A1/xx unknown
- 1993-09-02 US US08/116,386 patent/US5399702A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
HUT72747A (en) | 1996-05-28 |
EP0577003A1 (en) | 1994-01-05 |
UY23609A1 (es) | 1993-12-21 |
MX9303958A (es) | 1994-04-29 |
CN1087086A (zh) | 1994-05-25 |
HU9301881D0 (en) | 1993-09-28 |
NO932399L (no) | 1994-01-03 |
US5399702A (en) | 1995-03-21 |
JPH0680654A (ja) | 1994-03-22 |
US5273986A (en) | 1993-12-28 |
KR940005602A (ko) | 1994-03-21 |
AU4156293A (en) | 1994-01-06 |
BR9302737A (pt) | 1994-02-08 |
IL106141A0 (en) | 1993-10-20 |
ZA934603B (en) | 1994-01-05 |
AU667107B2 (en) | 1996-03-07 |
CA2099295A1 (en) | 1994-01-03 |
CZ133493A3 (en) | 1994-01-19 |
PL299544A1 (en) | 1994-02-21 |
NZ247988A (en) | 1995-11-27 |
NO932399D0 (no) | 1993-07-01 |
FI933037A (fi) | 1994-01-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI933037A0 (fi) | Tiazolylvinylfenylderivat | |
DE59303358D1 (de) | Quaterrylentetracarbonsäureimide | |
DE59306810D1 (de) | Gutbettwalzenmühle | |
AT399443B (de) | Sportschuh | |
BR9305745A (pt) | Quebra-luz | |
DE59301902D1 (de) | Kassenlade | |
DE59305364D1 (de) | Rotornut | |
DE69304512D1 (de) | Laseroszillator | |
DE69306208D1 (de) | Ablenkjoch | |
DE59304139D1 (de) | Polyanile | |
ATA227792A (de) | Sportschuh | |
BR9301712A (pt) | Aplainador | |
DE59309200D1 (de) | Bisphosphinoalkane | |
DE59301762D1 (de) | Chlorethylsulfonylbenzaldehyde | |
DE59206388D1 (de) | Kabeleckkanal | |
BR7200188U (pt) | Hidro-cinzeiro | |
ATA256392A (de) | Bandräumer | |
ATA58493A (de) | Lochstein | |
ATA27393A (de) | Alpinski | |
BR9203235A (pt) | Compactimer | |
BR7200229U (pt) | Doca-dupla | |
BR9203563A (pt) | Rotortranca | |
BR7200240U (pt) | Vari-watt | |
BR7200318U (pt) | Cabide sanfonado | |
BR7200879U (pt) | Cocho saleiro biazi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |